CXCL8 and cancer: While IL-17A acts as a potent inducer of T-cell-mediated antitumor immune responses, this cytokine was described as an essential activator of angiogenic factors, as well as an inducer of the proinflammatory factors IL-6 and IL-8 in cancer [35,45,46].